| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $20K | -66.8% | -63.3% |
| SG&A Expense | $3.6M | -21.1% | +2262.2% |
| Operating Income | -$3.7M | +21.8% | -1612.8% |
| Pre-tax Income | -$3.1M | +36.1% | -618.6% |
| Net Income | -$3.1M | +36.1% | -618.6% |
| EPS (Basic) | -$0.30 | +23.1% | +99.1% |
| EPS (Diluted) | -$0.30 | +23.1% | +99.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $7.7M | -12.1% | — |
| Total Assets | $15.1M | -15.9% | — |
| Current Liabilities | $3.6M | +1.4% | -12.8% |
| Long-term Debt | $55K | -48.6% | -86.6% |
| Total Liabilities | $3.7M | +1.2% | -13.6% |
| Stockholders' Equity | $10.5M | -27.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.9M | -51.5% | — |
| Capital Expenditures | $5K | +91.0% | — |
| Investing Cash Flow | -$5K | -91.0% | — |
| Financing Cash Flow | $3.5M | +38.2% | — |
| Free Cash Flow | -$2.9M | -51.6% | — |
| +351.3% |